Description:

Merolex (Meropenem) by Luex Healthcare is a broad-spectrum carbapenem antibiotic injection used to treat severe bacterial infections, including complicated intra-abdominal infections, pneumonia (including hospital-acquired and ventilator-associated), meningitis, septicemia, skin and soft tissue infections, gynecological infections, and febrile neutropenia. It is effective against many Gram-positive, Gram-negative, and anaerobic bacteria, including those resistant to other antibiotics. In Ghana (Accra), Merolex injection is a prescription antibiotic available in pharmacies and hospitals for serious infections requiring IV therapy.

Prescription:

Prescription-only (requires a doctor’s prescription in Ghana; dispensed by pharmacies or administered in hospitals/clinics with Rx for confirmed bacterial infection and sensitivity testing; not OTC due to serious infections, resistance concerns, and need for monitoring).

Therapeutic Category:

Carbapenem Antibiotic (Broad-spectrum beta-lactam antibacterial for serious infections.

Active Ingredients/Composition:

• Active ingredient: Meropenem trihydrate – equivalent to anhydrous meropenem 500 mg or 1 g per vial (most common strengths 500mg or 1g powder for solution). Other ingredients: Sodium carbonate (anhydrous) for constitution (to form meropenem sodium), sterile powder in vial. Reconstituted with water for injection or compatible IV fluid (e.g., 0.9% sodium chloride or 5% dextrose) to produce a clear solution.

Vitamins: None.

Minerals: None (trace sodium from sodium carbonate, but not therapeutic).

Variant:

• Merolex 500mg Injection (powder in vial for reconstitution).
• Merolex 1g Injection (higher dose for severe infections). The Luex Healthcare Merolex range includes both 500mg and 1000mg (1g) strengths; the queried “Merolex Meropenem Luex” typically refers to these injectable forms.

Consume Type:

Injectable – Intravenous (IV) infusion or slow IV bolus (powder reconstituted and diluted; administered only by healthcare professionals in clinical settings).

Directions/Usage: Administered only by trained healthcare personnel.

• Adults: Typical dose 500 mg to 1 g IV every 8 hours (or 2 g every 8 hours for meningitis); duration 7–14 days depending on infection.
• Children: Weight-based (10–40 mg/kg every 8 hours; max 2 g/dose).
• Reconstitute vial with sterile water for injection (5 ml for 500mg, 10 ml for 1g), then dilute further in compatible IV fluid (e.g., 50–200 ml) for infusion over 15–30 minutes.
• Slow IV bolus (over 3–5 minutes) possible for some doses.
• Adjust dose in renal impairment (reduce frequency or amount).
• Complete full course even if symptoms improve.

Common Side Effects: Common:

• Gastrointestinal: Nausea, vomiting, diarrhea, abdominal pain.
• Rash, pruritus (itching).
• Headache
• Injection site reactions (pain, phlebitis). Rare/serious (seek immediate help): Seizures, severe allergic reactions (anaphylaxis), Clostridium difficile-associated diarrhea, liver enzyme elevation, thrombocytopenia, or Stevens-Johnson syndrome.

Package Type:

Glass vial of powder (500mg or 1g per vial; often in packs of 1 or 10 vials; labelled carton with reconstitution instructions and warnings).

Storage Advice: Store unopened vials at room temperature (below 25–30°C) in original packaging, protected from light. Do not freeze. Reconstituted solution: Use immediately or store refrigerated (2–8°C) for up to 24 hours (check label). Diluted infusion: Use within 4–8 hours at room temperature or 24 hours refrigerated.

Safety Advice:

• Administered only under medical supervision (risk of seizures, anaphylaxis, and superinfections).
• Contraindicated in hypersensitivity to meropenem, other carbapenems, or beta-lactams.
• Caution in history of seizures, renal impairment (dose adjustment required), or central nervous system disorders.
• Monitor for superinfections (e.g., C. difficile diarrhoea).
• If rash, fever, seizures, or severe diarrhoea occur, stop use and seek medical care.
• Keep out of reach of children.

Product Substitutes: Similar meropenem injections in Ghana include:

• Meronem (original AstraZeneca brand, higher price if stocked).
• Generic meropenem 500mg or 1g injection (various importers).
• Other brands like Merocrit, Meronem, or local generics. Alternatives: Imipenem/cilastatin, ertapenem, or piperacillin/tazobactam for serious infections. Consult doctor/pharmacist in Accra (e.g., hospital pharmacy) for availability.

Manufacturer/Marketer:

Luex Healthcare Ltd (Ghana-based; produces Merolex as part of its antibiotic range). Marketed/distributed locally in Ghana by Luex Healthcare (often in partnership with Indian suppliers for API).

Country of Origin:

United Kingdom